A Case of Lymphangioleiomyomatosis Showing the Development of Mycobacterium abscessus subsp. massiliense Infection During Sirolimus Therapy
Among nontuberculous mycobacterial pulmonary diseases (NTM-PDs), Mycobacterium abscessus species pulmonary disease (MABS-PD) is one of the most severe and intractable infections. We herein report a 45-year-old woman with advanced lymphangioleiomyomatosis (LAM) who developed MABS-PD while undergoing sirolimus therapy. MABS-PD was immediately controlled using antibiotic therapy, although the patient's lung transplant registration was significantly delayed. To our knowledge, this is the first case report on the development of NTM-PD in a patient with LAM before lung transplantation. This case suggests that the early diagnosis and optimal treatment of NTM-PD are crucial in patients with advanced LAM.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Internal medicine (Tokyo, Japan) - (2023) vom: 27. Nov. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yanagisawa, Atsushi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Revised 26.11.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.2169/internalmedicine.2847-23 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364996617 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364996617 | ||
| 003 | DE-627 | ||
| 005 | 20231226100735.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2169/internalmedicine.2847-23 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1216.xml |
| 035 | |a (DE-627)NLM364996617 | ||
| 035 | |a (NLM)38008448 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yanagisawa, Atsushi |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A Case of Lymphangioleiomyomatosis Showing the Development of Mycobacterium abscessus subsp. massiliense Infection During Sirolimus Therapy |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 26.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Among nontuberculous mycobacterial pulmonary diseases (NTM-PDs), Mycobacterium abscessus species pulmonary disease (MABS-PD) is one of the most severe and intractable infections. We herein report a 45-year-old woman with advanced lymphangioleiomyomatosis (LAM) who developed MABS-PD while undergoing sirolimus therapy. MABS-PD was immediately controlled using antibiotic therapy, although the patient's lung transplant registration was significantly delayed. To our knowledge, this is the first case report on the development of NTM-PD in a patient with LAM before lung transplantation. This case suggests that the early diagnosis and optimal treatment of NTM-PD are crucial in patients with advanced LAM | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Lymphangioleiomyomatosis | |
| 650 | 4 | |a Mycobacterium abscessus species | |
| 650 | 4 | |a Nontuberculous mycobacterial pulmonary disease | |
| 650 | 4 | |a Sirolimus | |
| 700 | 1 | |a Takimoto, Takayuki |e verfasserin |4 aut | |
| 700 | 1 | |a Kurahara, Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Tsuyuguchi, Kazunari |e verfasserin |4 aut | |
| 700 | 1 | |a Yoshida, Shiomi |e verfasserin |4 aut | |
| 700 | 1 | |a Hirose, Masaki |e verfasserin |4 aut | |
| 700 | 1 | |a Inoue, Yoshikazu |e verfasserin |4 aut | |
| 700 | 1 | |a Arai, Toru |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Internal medicine (Tokyo, Japan) |d 1996 |g (2023) vom: 27. Nov. |w (DE-627)NLM012606731 |x 1349-7235 |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:27 |g month:11 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2169/internalmedicine.2847-23 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 27 |c 11 | ||